Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Rastatt

2 clinical trials in Rastatt, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Rastatt at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Rastatt

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
  • Sponsor:WSG Women's Cancer Study Group GmbH

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Rastatt

What the registry says about research in the country

01 Rastatt
Neoplasms
Rastatt’s sole research centre is actively recruiting two neoadjuvant studies that focus on breast cancer sub‑types, aiming to improve treatment outcomes for patients early in their disease course. Evaluation of a T‑DXD‑based regimen versus standard chemotherapy in HER2+ early breast cancer Comparison of sacituzumab govitecan alone and in combination with pembrolizumab for triple‑negative early breast cancer with low recurrence risk Assessment of safety through adverse event monitoring (CTCAE grade ≥ 3) in both trials Measurement of efficacy using pathological complete response and three‑year disease‑free survival endpoints These investigations seek to establish superior neoadjuvant strategies that could set new standards of care for early‑stage breast cancer patients in Germany and beyond.
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.